Basel Medical Group LtdBMGL
Price$3.12

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $8.9M0.0% YoYTTM through 30 Jun 2025
Net Income -$8.4MTTM through 30 Jun 2025
Free Cash Flow -$3.5MTTM through 30 Jun 2025

Margins

Current
Net Margin-94.0%

Returns

-163.2%ROE
-7.7%ROA

Balance Sheet Health

Debt / Equity0.59x
Current Ratio1.31x
Net Debt-$1.3Mnet cash position
Cash & Equivalents$2.3M

Quality Metrics

FCF Margin-38.9%

Multi-Year Trend

Revenue
'24'25
FY2025: $11.3M
Diluted EPS
'24'25
FY2025: $-0.57

Dividend

No dividend

Capital Allocation

Capex Intensity0.5%

Segment Performance

No segment data available.

Financials converted at 1.2707.
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.